Tulsa ER & Hospital now offers monoclonal antibody therapy as an alternative COVID-19 treatment option for those who meet the criteria mentioned below. The infusion therapies offered, including Eli Lilly’s bamlanivimab, and the combination of casirivimab and imdevimab, are under Emergency Use Authorization (EUA) issued by the U.S. Food and Drug Admisinstration (FDA). Casirivimab and…

Read More

Providing the care you deserve It may be hard to remember a time when anything other than COVID-19 came to mind when you thought of the hospital. And although our healthcare workers on the frontlines have certainly given this pandemic their all, hospital and emergency room care extend far beyond the coronavirus.  As we take…

Read More